Cardiology

Rivaroxaban cuts recurrent blood clots in obese patients

(HealthDay)—Real-world evidence shows that rivaroxaban reduces the risk for recurrent venous thromboembolism (VTE) in morbidly obese patients, with similar safety and efficacy as warfarin, according to a study published ...

Cardiology

Risk of venous thromboembolism recurrence high

(HealthDay)—The risk of recurrence after incident venous thromboembolism is high, particularly among patients with cancer-related venous thromboembolism, according to a study published in the September issue of The American ...

Cardiology

Reduced-dose anticoagulants feasible for extended VTE Tx

(HealthDay)—For an extended duration, reduced-dose direct oral anticoagulants (DOACs) may be as effective as full-dose treatment for preventing recurrent venous thromboembolism (VTE), according to a review published online ...

Cardiology

Rivaroxaban reduces VTE recurrence compared with aspirin

In patients at elevated risk for a recurrence of potentially life-threatening blood clots, a low dose of the oral blood-thinning medication rivaroxaban reduced recurrences more than three-fold compared with aspirin, with ...

Diseases, Conditions, Syndromes

Low risk of recurrent VTE for upper extremity DVT, SVT

(HealthDay)—Patients with upper extremity deep and superficial vein thrombosis (UEDVT and UESVT) have low risk of recurrent venous thromboembolism (VTE) but high mortality, according to a study published online Feb. 11 ...

Diseases, Conditions, Syndromes

Subclinical hypothyroidism may not up VTE recurrence risk

(HealthDay)—In the elderly, subclinical hypothyroidism is not associated with significantly increased risk of recurrent venous thromboembolism (rVTE), according to research published online Jan. 27 in the Journal of Thrombosis ...

Oncology & Cancer

ASCO: VTE is risk factor for recurrence in esophageal cancer

(HealthDay)—For patients with esophageal cancer, venous thromboembolism (VTE) is a risk factor for recurrence, according to a study presented at the American Society of Clinical Oncology's annual Gastrointestinal Cancers ...

Diseases, Conditions, Syndromes

Low D-dimer cut-off appears to help prevent recurrent events

(HealthDay)—Low cut-off levels used in the D-Dimer-Ultrasonography in Combination Italian Study (DULCIS) resulted in half the recurrent venous thromboembolism (VTE) events that would have occurred using other criteria in ...

Cardiology

Aspirin cuts risk of clots, DVT by a third, new study finds

Low dose aspirin lowers the occurrence of new venous blood clots – and represents a reasonable treatment option for patients who are not candidates for long-term anticoagulant drugs, such as warfarin, according to a new ...

page 1 from 2